Skip to main navigation
Skip to search
Skip to main content
WashU Medicine Research Profiles Home
Help & FAQ
Home
Profiles
Departments, Divisions and Centers
Research output
Search by expertise, name or affiliation
The Effect of Convalescent Plasma Therapy on Mortality Among Patients With COVID-19: Systematic Review and Meta-analysis
Stephen A. Klassen
, Jonathon W. Senefeld
, Patrick W. Johnson
, Rickey E. Carter
, Chad C. Wiggins
, Shmuel Shoham
, Brenda J. Grossman
,
Jeffrey P. Henderson
, James Musser
, Eric Salazar
, William R. Hartman
, Nicole M. Bouvier
, Sean T.H. Liu
, Liise Anne Pirofski
, Sarah E. Baker
, Noud van Helmond
, R. Scott Wright
, De Lisa Fairweather
, Katelyn A. Bruno
, Zhen Wang
Nigel S. Paneth, Arturo Casadevall, Michael J. Joyner
Show 3 others
Show less
Division of Laboratory and Genomic Medicine
Institute of Clinical and Translational Sciences (ICTS)
Division of Infectious Diseases
Roy and Diana Vagelos Division of Biology & Biomedical Sciences (DBBS)
COVID-19 Researchers
DBBS - Molecular Microbiology and Microbial Pathogenesis
Center for Women's Infectious Disease Research (cWIDR)
DBBS - Biochemistry, Biophysics, and Structural Biology
Research output
:
Contribution to journal
›
Review article
›
peer-review
120
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'The Effect of Convalescent Plasma Therapy on Mortality Among Patients With COVID-19: Systematic Review and Meta-analysis'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Meta-analysis
100%
Systematic Meta-analysis
100%
Patients with COVID-19
100%
Convalescent Plasma Therapy
100%
Randomized Clinical Trial
66%
Convalescent Plasma
66%
Low Mortality
33%
Patient Outcomes
33%
Hospitalized Patients
33%
Mortality Rate
33%
High Titer
33%
PubMed
33%
Therapeutic Agents
33%
2-dose
33%
Patient Mortality
33%
Hospital Admission
33%
MEDLINE
33%
Control Information
33%
Dose-response Study
33%
Random-effects Meta-analysis
33%
COVID-19 Impact
33%
Early Transfusion
33%
COVID-19 Convalescent Plasma
33%
Pharmacology, Toxicology and Pharmaceutical Science
Randomized Clinical Trial
100%
Mortality Rate
50%
Dose-Response Study
50%